Trestolone Acetate

Also known as: MENT, 7-alpha-methyl-19-nortestosterone

Status

In trials. No approved labeling. Investigated in clinical trials as a contraceptive; no FDA approval was found. Other countries were not verified for this entry. Schedule III controlled substance.

What it is

A highly potent androgen originally investigated as a male contraceptive.

What published research measured

Investigated by the Population Council as a male hormonal contraceptive, on the basis that it suppresses gonadotropins strongly while still maintaining androgenic tissue. That suppression is the point of the contraceptive research and the main hazard outside it. It aromatises to a potent estrogen at a high rate, so estrogenic effects are reported prominently. Human data comes from contraceptive trials, not from body composition studies.

Source

Not tied to a single designated source; see the published research on this molecule

Sources

No linked primary source is on file for this entry yet.

Educational use only, never medical advice. No doses.